Pediatric Oncology

Pediatric Oncology Outcomes of Patients Diagnosed with Acute Lymphoblastic Leukemia in the Years 2020-2022 at a Tertiary Hospital in the Philippines: The Philippine General Hospital Experience with the Covid-19 Pandemic
Kaira Monique Osmeña • Juan Paolo Torres • Pamela Fajardo
doi.org/10.69690/ODMJ-018-0425-943
Pediatric Oncology Epidemiological Profile of Childhood Cancer Worldwide, Lubumbashi University Clinic in the Republic of Congo
Criss Koba Mjumbe • Chadrack Kabeya
doi.org/10.69690/ODMJ-018-0425-1741
Pediatric Oncology SETBP-1 mutations favors transformation to AML in PTPN-11 positive JMML
Aditya Kumar Gupta • Ravi Kumar Majhi • Jagdish Prasad Meena • Pranay Tanwar • Anita Chopra • Sameer Bakshi
doi.org/10.69690/ODMJ-018-0425-1732
Pediatric Oncology Visual and quantitative assessment of interim 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in children with Hodgkin’s Lymphoma
Maksim Dunaykin • Gleb Shestopalov • Mikhail Yadgarov • Kailash Chaurasiya • Elena Kireeva • Natalya Myakova • Yury Likar
doi.org/10.69690/ODMJ-018-0425-618
Pediatric Oncology Improving Treatment Methods for Immature Teratoma Ovaries in Children and Adolescence
Anvar Shukullaev • Djamilya Polatova • Khusan Saitov • Nargiza Mansurova • Anora Khayitova • Ezozakhon Azimova • Aleksandr Savkin
doi.org/10.69690/ODMJ-018-0425-501
Pediatric Oncology Psychosocial experience of parents with children diagnosed with cancer in Lubumbashi
Criss Koba Mjumbe • Béatrice Koba • Jean Pierre Birangui
doi.org/10.69690/ODMJ-018-0425-1730
Pediatric Oncology Allogeneic Stem-Cell Transplantation Following Chimeric Antigen Receptor T-Cell for the Treatment of Relapsed/Refractory Hematologic Malignancy in Pediatrics and Young Adults: A Systematic Review and Meta-Analysis of Clinical Studies
Edi Tehuteru • Nicholas Adrianto • Stella Kallista • Reganedgary Jonlean
doi.org/10.69690/ODMJ-018-0425-1030
Pediatric Oncology Beyond End-of-Life: Integrating Pediatric Palliative Care into Oncology Teams to Improve Holistic Outcomes
Qutaibah Alotaibi • Nisreen Khalifa
doi.org/10.69690/ODMJ-018-0425-1721
Pediatric Oncology Nasopharyngeal carcinoma treatment in children and adolescents: Gemcitabine + Cisplatin and Gemcitabine + Cisplatin + Pembrolizumab Induction Chemotherapy
Lilia Rabaeva • Nikolay Zhukov
doi.org/10.69690/ODMJ-018-0425-1028
Pediatric Oncology Langerhans Cell Histiocytosis (LCH) in Uzbekistan: Analysis of prognostic factors and outcomes
Khilola Rustamova • Djamila Polatova • Lola Kasimbekova • Anora Haitova • Yorbek Soliev • Kamola Kaharova • Abdulaziz Rustamov
doi.org/10.69690/ODMJ-018-0425-1718
Pediatric Oncology Investigation of Total Diagnostic Interval for Pediatric Brain Tumors Referred to MAHAK Hospital
Mandana Tasbihi • Mithra Ghalibafian • Mahyar Nourian • Sahar Arbab Solimani • Negin Jafariyan Lahijani
doi.org/10.69690/ODMJ-018-0425-1705
Pediatric Oncology Low Dose Olanzapine for the Prevention and Treatment of Chemotherapy-Induced Nausea and Vomiting in Children and Adolescents: Results of a Randomized Phase 3 trial (OZONE-V)
Lilia Rabaeva • Nikolay Zhukov
doi.org/10.69690/ODMJ-018-0425-1025